443 related articles for article (PubMed ID: 32992445)
1. Non-Invasive Biomarkers for Early Detection of Breast Cancer.
Li J; Guan X; Fan Z; Ching LM; Li Y; Wang X; Cao WM; Liu DX
Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32992445
[TBL] [Abstract][Full Text] [Related]
2. [Biomarkers for early screening and diagnosis of breast cancer: a review].
Liang Y; Hao M; Guo R; Li X; Li Y; Yu C; Yang Z
Sheng Wu Gong Cheng Xue Bao; 2023 Apr; 39(4):1425-1444. PubMed ID: 37154315
[TBL] [Abstract][Full Text] [Related]
3. Circulating tumor biomarkers in early-stage breast cancer: characteristics, detection, and clinical developments.
Qiu J; Qian D; Jiang Y; Meng L; Huang L
Front Oncol; 2023; 13():1288077. PubMed ID: 37941557
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of nipple aspirate fluid as a diagnostic tool for early detection of breast cancer.
Shaheed SU; Tait C; Kyriacou K; Linforth R; Salhab M; Sutton C
Clin Proteomics; 2018; 15():3. PubMed ID: 29344009
[TBL] [Abstract][Full Text] [Related]
5. Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2007; 7(1):1-32. PubMed ID: 23074501
[TBL] [Abstract][Full Text] [Related]
6. Biomarker Reproducibility Challenge: A Review of Non-Nucleotide Biomarker Discovery Protocols from Body Fluids in Breast Cancer Diagnosis.
Safari F; Kehelpannala C; Safarchi A; Batarseh AM; Vafaee F
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345117
[TBL] [Abstract][Full Text] [Related]
7. Shotgun proteomics coupled to nanoparticle-based biomarker enrichment reveals a novel panel of extracellular matrix proteins as candidate serum protein biomarkers for early-stage breast cancer detection.
Fredolini C; Pathak KV; Paris L; Chapple KM; Tsantilas KA; Rosenow M; Tegeler TJ; Garcia-Mansfield K; Tamburro D; Zhou W; Russo P; Massarut S; Facchiano F; Belluco C; De Maria R; Garaci E; Liotta L; Petricoin EF; Pirrotte P
Breast Cancer Res; 2020 Dec; 22(1):135. PubMed ID: 33267867
[TBL] [Abstract][Full Text] [Related]
8. Molecular and Circulating Biomarkers of Gastric Cancer.
Jelski W; Mroczko B
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886934
[TBL] [Abstract][Full Text] [Related]
9. Emergence of Circulating MicroRNAs in Breast Cancer as Diagnostic and Therapeutic Efficacy Biomarkers.
Aggarwal V; Priyanka K; Tuli HS
Mol Diagn Ther; 2020 Apr; 24(2):153-173. PubMed ID: 32067191
[TBL] [Abstract][Full Text] [Related]
10. The use of minimally invasive biomarkers for the diagnosis and prognosis of hepatocellular carcinoma.
Trevisan França de Lima L; Broszczak D; Zhang X; Bridle K; Crawford D; Punyadeera C
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188451. PubMed ID: 33065194
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes of screening and diagnostic mammography in a limited resource healthcare system.
Al-Balas M; Al-Balas H; AlAmer Z; Al-Taweel G; Ghabboun A; Al Bzoor F; Abumkarab S; Bakr TA; Eleiwat B
BMC Womens Health; 2024 Mar; 24(1):191. PubMed ID: 38515093
[TBL] [Abstract][Full Text] [Related]
12. Advances in Electrochemical Biosensor Technologies for the Detection of Nucleic Acid Breast Cancer Biomarkers.
Chiorcea-Paquim AM
Sensors (Basel); 2023 Apr; 23(8):. PubMed ID: 37112468
[TBL] [Abstract][Full Text] [Related]
13. Crucial considerations for pipelines to validate circulating biomarkers for breast cancer.
Ewaisha R; Gawryletz CD; Anderson KS
Expert Rev Proteomics; 2016; 13(2):201-11. PubMed ID: 26653344
[TBL] [Abstract][Full Text] [Related]
14. Nipple Aspirate Fluid at a Glance.
Patuleia SIS; Suijkerbuijk KPM; van der Wall E; van Diest PJ; Moelans CB
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008326
[TBL] [Abstract][Full Text] [Related]
15. Non-invasive proteomics-thinking about personalized breast cancer screening and treatment.
Debald M; Wolfgarten M; Walgenbach-Brünagel G; Kuhn W; Braun M
EPMA J; 2010 Sep; 1(3):413-20. PubMed ID: 23199085
[TBL] [Abstract][Full Text] [Related]
16. Cell-free miRNAs as non-invasive biomarkers in breast cancer: Significance in early diagnosis and metastasis prediction.
Kashyap D; Kaur H
Life Sci; 2020 Apr; 246():117417. PubMed ID: 32044304
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide cell-free DNA methylation analyses improve accuracy of non-invasive diagnostic imaging for early-stage breast cancer.
Liu J; Zhao H; Huang Y; Xu S; Zhou Y; Zhang W; Li J; Ming Y; Wang X; Zhao S; Li K; Dong X; Ma Y; Qian T; Chen X; Xing Z; Zhang Y; Chen H; Liu Z; Pang D; Zhou M; Wu Z; Wang X; Wang X; Wu N; Su J
Mol Cancer; 2021 Feb; 20(1):36. PubMed ID: 33608029
[TBL] [Abstract][Full Text] [Related]
18. The use of cell free DNA in the diagnosis of HCC.
Banini BA; Sanyal AJ
Hepatoma Res; 2019; 5():. PubMed ID: 31673629
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic yield of primary circulating tumor cells in women suspected of breast cancer: the BEST (Breast Early Screening Test) study.
Murray NP; Miranda R; Ruiz A; Droguett E
Asian Pac J Cancer Prev; 2015; 16(5):1929-34. PubMed ID: 25773847
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
